Vanguard Group’s BioTelemetry, Inc. BEAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-3,486,540
| Closed | -$251M | – | 4381 |
|
|
2020
Q4 | $251M | Sell |
3,486,540
-223,396
| -6% | -$11.7M | 0.01% | 1328 |
|
|
2020
Q3 | $169M | Sell |
3,709,936
-132,545
| -3% | -$5.54M | 0.01% | 1376 |
|
|
2020
Q2 | $174M | Sell |
3,842,481
-663
| -0% | -$29.7K | 0.01% | 1358 |
|
|
2020
Q1 | $148M | Buy |
3,843,144
+75,399
| +2% | +$3.47M | 0.01% | 1311 |
|
|
2019
Q4 | $174M | Sell |
3,767,745
-58,424
| -2% | -$2.53M | 0.01% | 1459 |
|
|
2019
Q3 | $156M | Buy |
3,826,169
+127,993
| +3% | +$5.53M | 0.01% | 1485 |
|
|
2019
Q2 | $178M | Buy |
3,698,176
+195,534
| +6% | +$10.3M | 0.01% | 1429 |
|
|
2019
Q1 | $219M | Buy |
3,502,642
+766,297
| +28% | +$52.6M | 0.01% | 1277 |
|
|
2018
Q4 | $163M | Buy |
2,736,345
+836,228
| +44% | +$50.2M | 0.01% | 1375 |
|
|
2018
Q3 | $122M | Buy |
1,900,117
+52,363
| +3% | +$2.92M | ﹤0.01% | 1700 |
|
|
2018
Q2 | $83.1M | Buy |
1,847,754
+63,771
| +4% | +$2.54M | ﹤0.01% | 1869 |
|
|
2018
Q1 | $55.4M | Buy |
1,783,983
+71,292
| +4% | +$2.34M | ﹤0.01% | 2021 |
|
|
2017
Q4 | $51.2M | Buy |
1,712,691
+45,015
| +3% | +$1.3M | ﹤0.01% | 2046 |
|
|
2017
Q3 | $55M | Buy |
1,667,676
+155,813
| +10% | +$5.4M | ﹤0.01% | 1988 |
|
|
2017
Q2 | $50.6M | Sell |
1,511,863
-162,717
| -10% | -$4.85M | ﹤0.01% | 2012 |
|
|
2017
Q1 | $48.5M | Buy |
1,674,580
+174,844
| +12% | +$4.33M | ﹤0.01% | 2026 |
|
|
2016
Q4 | $33.5M | Buy |
1,499,736
+85,586
| +6% | +$1.67M | ﹤0.01% | 2165 |
|
|
2016
Q3 | $26.3M | Buy |
1,414,150
+249,607
| +21% | +$4.71M | ﹤0.01% | 2244 |
|
|
2016
Q2 | $19M | Buy |
1,164,543
+137,950
| +13% | +$2.03M | ﹤0.01% | 2354 |
|
|
2016
Q1 | $12M | Buy |
1,026,593
+31,757
| +3% | +$355K | ﹤0.01% | 2512 |
|
|
2015
Q4 | $11.6M | Buy |
994,836
+48,081
| +5% | +$608K | ﹤0.01% | 2559 |
|
|
2015
Q3 | $11.6M | Buy |
946,755
+26,997
| +3% | +$344K | ﹤0.01% | 2532 |
|
|
2015
Q2 | $8.67M | Buy |
919,758
+22,245
| +2% | +$206K | ﹤0.01% | 2755 |
|
|
2015
Q1 | $7.94M | Buy |
897,513
+46,136
| +5% | +$466K | ﹤0.01% | 2762 |
|
|
2014
Q4 | $8.54M | Buy |
851,377
+14,901
| +2% | +$128K | ﹤0.01% | 2616 |
|
|
2014
Q3 | $5.61M | Buy |
836,476
+16,757
| +2% | +$117K | ﹤0.01% | 2763 |
|
|
2014
Q2 | $5.88M | Buy |
819,719
+41,765
| +5% | +$332K | ﹤0.01% | 2756 |
|
|
2014
Q1 | $7.85M | Buy |
777,954
+106,468
| +16% | +$980K | ﹤0.01% | 2601 |
|
|
2013
Q4 | $5.33M | Buy |
671,486
+32,400
| +5% | +$302K | ﹤0.01% | 2769 |
|
|
2013
Q3 | $6.33M | Buy |
639,086
+64,600
| +11% | +$508K | ﹤0.01% | 2615 |
|
|
2013
Q2 | $3.39M | Buy |
+574,486
| New | +$1.93M | ﹤0.01% | 2870 |
|
Other funds holding BEAT
Vanguard Group's BEAT Position: Q1 2021 in Review
Vanguard Group sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 3,486,540 shares — an estimated $251M sold.
Vanguard Group first reported a position in BEAT in Q2 2013 and held it in 31 quarters. The position peaked at $251M in Q4 2020. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.
- Vanguard Group reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
- Vanguard Group sold 3,486,540 BioTelemetry, Inc. shares in Q1 2021, an estimated $251M.
- Vanguard Group first reported a position in BioTelemetry, Inc. in Q2 2013 and held it in 31 quarters.
- Vanguard Group's BioTelemetry, Inc. position peaked at $251M in Q4 2020.
- 1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.
Based on Vanguard Group's 13F filing for Q1 2021, filed 14 May 2021.